Literature DB >> 17992656

Design of an advanced temporary hip prosthesis for an effective recovery of septic mobilizations: a preliminary study.

S Danti1, C Rizzo, G Polacco, M G Cascone, P Giusti, M Lisanti.   

Abstract

The purpose of this study was the design and preliminary feasibility study of an advanced temporary hip prosthesis acting as an in-site drug dispensing system. An interactive device was designed to improve the recovery of bone infections compared to the mechanical spacers currently used in septic mobilizations. A commercial device was chosen and modified specifically for the purpose. First of all, the device was provided with a hydraulic multi-channel system connected via catheter to a subcutaneous valve, refillable with a drug aqueous solution from the outside. Moreover, since it allows samples of biological fluids for analyses to be drawn directly from the implantation site, this chemical dispensing system was designed to allow the course of infections to be monitored and customized therapies to be dosed. The insertion of biocompatible membranes inside the channel ends was considered essential to prevent their occlusion by fibrous tissue growth, thereby preserving the device functionality. Moreover, a biodegradable spongy ring was designed to be fixed onto the stem in distal position both to give primary stability to the implant and to act simultaneously as a scaffold for bonelike cell growth.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17992656     DOI: 10.1177/039139880703001012

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  1 in total

1.  Growing bone tissue-engineered niches with graded osteogenicity: an in vitro method for biomimetic construct assembly.

Authors:  Serena Danti; Lorenzo Pio Serino; Delfo D'Alessandro; Stefania Moscato; Sabrina Danti; Luisa Trombi; Dinuccio Dinucci; Federica Chiellini; Andrea Pietrabissa; Michele Lisanti; Stefano Berrettini; Mario Petrini
Journal:  Tissue Eng Part C Methods       Date:  2013-04-30       Impact factor: 3.056

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.